Karen Sebaski Quoted in Law360 and IPWatchdog on U.S. v. Anthrex SCOTUS Decision

Karen provided insights on the highly anticipated Supreme Court decision in U.S. v. Arthrex, which gives the U.S. Patent and Trademark Office director the right to review Patent Trial and Appeal Board decisions. Karen notes, “given its potential to broadly impact the PTAB and all of its decisions, Arthrex has been closely watched,” adding the USPTO director role is “even more important now.” Read her insights in Law360 here and IPWatchdog here.